Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) Short Interest Update

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) saw a significant increase in short interest in October. As of October 31st, there was short interest totalling 702,600 shares, an increase of 1,984.9% from the October 15th total of 33,700 shares. Based on an average daily trading volume, of 1,540,000 shares, the short-interest ratio is presently 0.5 days. Approximately 34.8% of the shares of the stock are short sold.

Shuttle Pharmaceuticals Trading Down 1.7 %

Shuttle Pharmaceuticals stock traded down $0.02 during mid-day trading on Wednesday, reaching $1.13. The company had a trading volume of 39,620 shares, compared to its average volume of 471,894. Shuttle Pharmaceuticals has a 1 year low of $1.03 and a 1 year high of $4.95. The business’s 50-day simple moving average is $1.40.

Shuttle Pharmaceuticals (NASDAQ:SHPH) last issued its earnings results on Tuesday, September 3rd. The company reported ($0.96) earnings per share (EPS) for the quarter.

Shuttle Pharmaceuticals Company Profile

Shuttle Pharmaceuticals Holdings, Inc, a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers .